Agenda
ATMP Sweden 2026 brings academia, healthcare and industry together around a single question: what needs to change for advanced therapies to reach patients at scale?
Over two days the programme covers emerging science from Swedish and Nordic research groups, regulatory and manufacturing routes that carry it toward the clinic, the trial infrastructure and capability that puts it in front of patients, and the funding and reimbursement models that decide whether it stays there. Throughout it all are the translational journeys behind the field, successes and failures alike, and the patient voices that gives the work purpose.
| Time | Day 1 – Tuesday 1 December, 8:00-18:00 | Topic | Chairs & Co-Chairs | Speakers |
|---|---|---|---|---|
| 8:00 | Venue Opening & Registration | |||
| 8:45 | Opening Adress | |||
| 9:00 | Session 1 Plenary: | From Breakthrough Science to Patient Impact | Matti Sällberg, Karolinska Institute Eva-Karin Gidlund, NorthX Biologics | Di Yu, Uppsala University, Elicera Therapeutics AB Mark Farmery, Anocca AB Andrea Salmén, NeoGap Therapeutics AB Knut Steffensen, Karolinska ATMP Center |
| 10:00 | Break | |||
| 10:30 | Session 1 Plenary (Continued): | From Breakthrough Science to Patient Impact | More speakers to be confirmed | |
| 11:30 | Lunch & Mingle | |||
| 13:00 | Session 2: | Regulatory Pathways and Accelerated Development in the Nordics and EU | Anna Koptina Gültekin, AI4RA Björn Carlsson, SSI Strategy | Stine Kihl-Plambek, ATMP Denmark Anna Koptina Gültekin, AI4RA Björn Carlsson, SSI Strategy Alessandro Aiuti, San Raffaele Telethon Institute |
| 14:00 | Break | |||
| 14:30 | Session 2 (Continued): | Regulatory Pathways and Accelerated Development in the Nordics and EU | Panel Discussion | |
| 15:30 | Session 3: | Frontiers in ATMP Discovery and Innovation + Poster Session | Pierfrancesco Pagella, Linköping University Mattias Magnusson, Lund University Johan Flygare, Lund University Fredrik Lanner, Karolinska Institutet Anna Pasetto, Oslo University Hospital | Malin Parmar, Lund University Selected abstract presentations |
| 16:00 | Break | |||
| 16:30 | Session 3 (Continued): | Frontiers in ATMP Discovery and Innovation | Selected abstract presentations Karl Johan Malmberg, Karolinska Institutet | |
| 18:00-Late | After Work + Poster Session | |||
| Time | Day 2 – Wednesday 2 December, 8:30-18:30 | Topic | Chairs & Co-Chairs | Speakers |
|---|---|---|---|---|
| 8:30 | Venue Opening & Registration | |||
| 9:00 | Session 4: | Clinical Advancement and Challenges in ATMP for the Brain | Mats Hellström, Uppsala University Hjalmar Bjartmarz, Skåne University Hospital | Xiuming Liang, Karolinska Institute Mats Hellström, Uppsala University Hjalmar Bjartmarz, Skåne University Hospital |
| 10:00 | Break | |||
| 10:30 | Session 4 (Continued): | Clinical Advancement and Challenges in ATMP for the Brain | Fredrik Swartling, Uppsala University More speakers to be confirmed | |
| 11:30 | Lunch & Mingle | |||
| 13:00 | Session 5: | From Price Tags to Payment Pathways | Dag Larsson, Lif Jim Lund, CCRM Nordic Magdalena Bengtsson Levin, Johnson & Johnson | Francis Pang, ARM More speakers to be confirmed |
| 14:00 | Break | |||
| 14:30 | Session 5 (Continued): | From Price Tags to Payment Pathways | More speakers to be confirmed | |
| 15:30 | Session 6: | Clinical Translation / Innovation Network and the Patient Impact | Hannah Karlsson, ATMP Uppsala, CGT Sweden NACNET Helena Luning, SweTrial | Hannah Karlsson, ATMP Uppsala, CGT Sweden NACNET Kristina Kannisto, SweTrial Antonia Mueller, Medical University of Vienna Natasha Bank, ATMP Flemingsberg |
| 16:00 | Break | |||
| 16:30 | Session 6 (Continued): | Clinical Translation / Innovation Network and the Patient Impact | More speakers to be confirmed | |
| 18:00 | Closing Adress | |||
The agenda is still taking shape – session names, timing, and other details are subject to change.